Eastwood Bio-Medical Canada Inc.
EBM.V
TSX
| 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 8.41% | -11.35% | -2.29% | -5.14% | -19.86% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 8.41% | -11.35% | -2.29% | -5.14% | -19.86% |
| Cost of Revenue | -9.23% | -14.94% | -9.48% | -19.25% | -23.14% |
| Gross Profit | 18.02% | -9.15% | 2.21% | 4.30% | -17.91% |
| SG&A Expenses | 3.31% | -11.52% | -5.83% | -14.26% | -21.02% |
| Depreciation & Amortization | -60.00% | -34.18% | -10.20% | 14.05% | -1.25% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -5.83% | -14.56% | -7.11% | -12.96% | -19.93% |
| Operating Income | 32.17% | 19.57% | 14.30% | 25.19% | 20.01% |
| Income Before Tax | 29.16% | 16.91% | 6.12% | 17.89% | 17.39% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 29.16% | 16.91% | 6.12% | 17.89% | 17.39% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 29.16% | 16.91% | 6.12% | 17.89% | 17.39% |
| EBIT | 32.17% | 19.57% | 14.30% | 25.19% | 20.01% |
| EBITDA | 21.18% | 18.54% | 19.39% | 39.42% | 28.55% |
| EPS Basic | 30.61% | 17.31% | 7.55% | 18.97% | 16.95% |
| Normalized Basic EPS | 29.03% | 18.18% | 6.06% | 16.67% | 16.22% |
| EPS Diluted | 30.61% | 17.31% | 7.55% | 18.97% | 16.95% |
| Normalized Diluted EPS | 29.03% | 18.18% | 6.06% | 16.67% | 16.22% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |